Bicara Therapeutics Inc. (BCAX) Reports Q3 Loss of $0.67
Tweet
Share
E-mailGet Alerts BCAX Hot Sheet
Join SI Premium – FREE
Bicara Therapeutics Inc. (NASDAQ: BCAX) reported Q3 EPS of ($0.67).
For earnings history and earnings-related data on Bicara Therapeutics Inc. (BCAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Momo (MOMO) Tops Q2 EPS by 8c; offers guidance
- Kotak Starts Aequs Ltd (AEQUS:IN) at Reduce (3)
- Bernstein SocGen Group Starts SSE Plc. (SSE:LN) (SSEZY) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
